These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24982661)

  • 61. Cytidine-phosphate-guanosine oligodeoxynucleotides in combination with CD40 ligand decrease periodontal inflammation and alveolar bone loss in a TLR9-independent manner.
    Zhao Q; Hu Y; Deng S; Yu P; Chen B; Wang Z; Han X
    J Appl Oral Sci; 2018; 26():e20170451. PubMed ID: 29791566
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.
    Wilson R; Makuch M; Kienzler AK; Varley J; Taylor J; Woodhall M; Palace J; Leite MI; Waters P; Irani SR
    Brain; 2018 Apr; 141(4):1063-1074. PubMed ID: 29447335
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation.
    van Zelm MC; Bartol SJ; Driessen GJ; Mascart F; Reisli I; Franco JL; Wolska-Kusnierz B; Kanegane H; Boon L; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Jul; 134(1):135-44. PubMed ID: 24418477
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease.
    Palacios F; Moreno P; Morande P; Abreu C; Correa A; Porro V; Landoni AI; Gabus R; Giordano M; Dighiero G; Pritsch O; Oppezzo P
    Blood; 2010 Jun; 115(22):4488-96. PubMed ID: 20233972
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alphavirus-induced encephalomyelitis: antibody-secreting cells and viral clearance from the nervous system.
    Metcalf TU; Griffin DE
    J Virol; 2011 Nov; 85(21):11490-501. PubMed ID: 21865385
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells.
    Dicker F; Kater AP; Fukuda T; Kipps TJ
    Blood; 2005 Apr; 105(8):3193-8. PubMed ID: 15339846
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells.
    Huggins J; Pellegrin T; Felgar RE; Wei C; Brown M; Zheng B; Milner EC; Bernstein SH; Sanz I; Zand MS
    Blood; 2007 Feb; 109(4):1611-9. PubMed ID: 17032927
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rapid Proliferation and Differentiation of a Subset of Circulating IgM Memory B Cells to a CpG/Cytokine Stimulus In Vitro.
    Vásquez C; Franco MA; Angel J
    PLoS One; 2015; 10(10):e0139718. PubMed ID: 26439739
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation.
    Pittner BT; Shanafelt TD; Kay NE; Jelinek DF
    Leukemia; 2005 Dec; 19(12):2264-72. PubMed ID: 16208411
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Do CLL B cells correspond to naive or memory B-lymphocytes? Evidence for an active Ig switch unrelated to phenotype expression and Ig mutational pattern in B-CLL cells.
    Oppezzo P; Magnac C; Bianchi S; Vuillier F; Tiscornia A; Dumas G; Payelle-Brogard B; Ajchenbaum-Cymbalista F; Dighiero G; Pritsch O
    Leukemia; 2002 Dec; 16(12):2438-46. PubMed ID: 12454750
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
    Marantidou F; Dagklis A; Stalika E; Korkolopoulou P; Saetta A; Anagnostopoulos A; Laoutaris N; Stamatopoulos K; Belessi C; Scouras Z; Patsouris E
    Blood Cells Mol Dis; 2010 Apr; 44(4):262-7. PubMed ID: 20117026
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Characteristics and clinical significance of immunophenotype in chronic lymphocytic leukemia].
    Kuang WY; Zhang GS; Xiao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):662-6. PubMed ID: 16114552
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3.
    Kindler V; Zubler RH
    J Immunol; 1997 Sep; 159(5):2085-90. PubMed ID: 9278293
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
    Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
    Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.
    Chen L; Li J; Zheng W; Zhang Y; Wu Y; Li L; Qian S; Xu W
    Leuk Lymphoma; 2007 Sep; 48(9):1785-92. PubMed ID: 17786715
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells.
    Patz M; Isaeva P; Forcob N; Müller B; Frenzel LP; Wendtner CM; Klein C; Umana P; Hallek M; Krause G
    Br J Haematol; 2011 Feb; 152(3):295-306. PubMed ID: 21155758
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification.
    Dono M; Hashimoto S; Fais F; Trejo V; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Sellars B; Gregersen PK; Ferrarini M; Chiorazzi N
    Blood; 1996 Feb; 87(4):1586-94. PubMed ID: 8608251
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Induction of proliferation and differentiation of leukaemic B cells from patients with chronic lymphocytic leukaemia by anti-mu and conditioned medium.
    Steinberg J; Moore MA; Bernhardt B; Bona CA; Platsoucas CD
    Scand J Immunol; 1987 Jun; 25(6):599-611. PubMed ID: 3110941
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
    Buhmann R; Nolte A; Westhaus D; Emmerich B; Hallek M
    Blood; 1999 Mar; 93(6):1992-2002. PubMed ID: 10068672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.